After several years of intensive work, Naturex has developed a patented and scientifically proven ingredient that answers the need of more than 79 million Americans for controlling their blood sugar.
To help manage post-prandial glucose peaks in healthy people, Naturex is the first to offer Glucevia™, a natural extract of Fraxinus excelsior derived from seeds/fruits. “Common ash (Fraxinus excelsior) has long been used by Mediterranean populations for its hypoglycemic effect, but until now few scientific studies had been conducted,” explained Elizabeth Bui, business unit director for nutrition and health. “Naturex was able to demonstrate the efficacy and safety of this unique extract on blood sugar control via in vitro, in vivo and three clinical studies,” she added.
Thanks to a proprietary extraction, Naturex has developed a patented extract standardized to 10 percent Nuzhenide and GI3. This extract was tested in several clinical studies targeted at different populations. The latest one was a randomized, double-blind, placebo-controlled, cross-over clinical study in which overweight and mature volunteers received 1,000 mg of Glucevia per day for 3 weeks. The results showed that post-prandial glycemia expressed as Area Under the Curve (AUC) was significantly reduced by 28.2 percent versus baseline.
Glucevia is able to work on all types of sugars both complex and simple. This is in contrast with other products available on the market. “We think Glucevia acts directly on the liver, helping it to stay healthy and better perform its daily functions,” said Bui. The liver plays a key role in glucose homeostasis and maintaining its health status is part of a strategy to manage blood sugar levels.
Naturex launched Glucevia in the North American market during Supply Side West in Las Vegas, Nov. 14 to 15. As a new ingredient within the NAT life range, it will be supported by in-depth technical documentation and marketing supports such as specific branding, a dedicated website and marketing campaign.